{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:00:38Z","timestamp":1782554438709,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T00:00:00Z","timestamp":1186963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2007,9,29]]},"DOI":"10.1007\/s10552-007-9049-x","type":"journal-article","created":{"date-parts":[[2007,8,12]],"date-time":"2007-08-12T11:07:34Z","timestamp":1186916854000},"page":"1095-1105","source":"Crossref","is-referenced-by-count":72,"title":["IL6 genotypes and colon and rectal cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Martha L.","family":"Slattery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette J.","family":"Caan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,13]]},"reference":[{"key":"9049_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197107012850103","volume":"285","author":"GJ Devroede","year":"1971","unstructured":"Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB (1971) Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285:17\u201321","journal-title":"N Engl J Med"},{"key":"9049_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1097-0142(196405)17:5<657::AID-CNCR2820170515>3.0.CO;2-7","volume":"17","author":"MB Goldgraber","year":"1964","unstructured":"Goldgraber MB, Kirsner JB (1964) Carcinoma of the Colon in Ulcerative Colitis. Cancer 17:657\u2013665","journal-title":"Cancer"},{"key":"9049_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.159.2.161","volume":"159","author":"W Smalley","year":"1999","unstructured":"Smalley W, Ray WA, Daugherty J, Griffin MR (1999) Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 159:161\u2013166","journal-title":"Arch Intern Med"},{"key":"9049_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","volume":"81","author":"JP Collet","year":"1999","unstructured":"Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L (1999) Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 81:62\u201368","journal-title":"Br J Cancer"},{"key":"9049_CR5","first-page":"5575","volume":"52","author":"LJ Marnett","year":"1992","unstructured":"Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Research 52:5575\u20135589","journal-title":"Cancer Research"},{"key":"9049_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2004.04.002","volume":"27","author":"H Bozcuk","year":"2004","unstructured":"Bozcuk H, Uslu G, Samur M, Yildiz M, Ozben T, Ozdogan M, Artac M, Altunbas H, Akan I, Savas B (2004) Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 27:58\u201365","journal-title":"Cytokine"},{"key":"9049_CR7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ijc.10143","volume":"98","author":"G Mantovani","year":"2002","unstructured":"Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, Lusso MR, Mulas C, Mudu MC, Murgia V, Camboni P, Massa E, Ferreli L, Contu P, Rinaldi A, Sanjust E, Atzei D, Elsener B (2002) Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 98:84\u201391","journal-title":"Int J Cancer"},{"key":"9049_CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.10833","volume":"103","author":"R Salgado","year":"2003","unstructured":"Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY (2003) Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103:642\u2013646","journal-title":"Int J Cancer"},{"key":"9049_CR9","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/0008-5472.CAN-05-3631","volume":"66","author":"MJ Gunter","year":"2006","unstructured":"Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483\u20132487","journal-title":"Cancer Res"},{"key":"9049_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.291.5.585","volume":"291","author":"TP Erlinger","year":"2004","unstructured":"Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. Jama 291:585\u2013590","journal-title":"Jama"},{"key":"9049_CR11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ejca.2006.01.008","volume":"42","author":"KJ Helzlsouer","year":"2006","unstructured":"Helzlsouer KJ, Erlinger TP, Platz EA (2006) C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42:704\u2013707","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"9049_CR12","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2188\/jea.15.S185","volume":"15","author":"Y Ito","year":"2005","unstructured":"Ito Y, Suzuki K, Tamakoshi K, Wakai K, Kojima M, Ozasa K, Watanabe Y, Kawado M, Hashimoto S, Suzuki S, Tokudome S, Toyoshima H, Hayakawa N, Kato K, Watanabe M, Ohta Y, Maruta M, Tamakoshi A (2005) Colorectal cancer and serum C-reactive protein levels: a case\u2013control study nested in the JACC Study. J Epidemiol 15(Suppl 2):S185\u2013S189","journal-title":"J Epidemiol"},{"key":"9049_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-142-6-200503150-00008","volume":"142","author":"SM Zhang","year":"2005","unstructured":"Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425\u2013432","journal-title":"Ann Intern Med"},{"key":"9049_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2002-020092","volume":"88","author":"SL Ferrari","year":"2003","unstructured":"Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL (2003) Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88:255\u2013259","journal-title":"J Clin Endocrinol Metab"},{"key":"9049_CR15","doi-asserted-by":"crossref","unstructured":"Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, Tornvall P (2004) Genetic predisposition of the Interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem","DOI":"10.1373\/clinchem.2004.037531"},{"key":"9049_CR16","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1210\/jc.2003-031101","volume":"89","author":"M Mohlig","year":"2004","unstructured":"Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, Bergmann MM, Ristow M, Hoffmann K, Pfeiffer AF (2004) Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 89:1885\u20131890","journal-title":"J Clin Endocrinol Metab"},{"key":"9049_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1158\/1055-9965.EPI-06-0667","volume":"16","author":"ML Slattery","year":"2007","unstructured":"Slattery ML, Curtin K, Baumgartner R, Sweeney C, Byers T, Giuliano AR, Baumgartner KB, Wolff RR (2007) IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern united states. Cancer Epidemiol Biomarkers Prev 16:747\u2013755","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369\u20131376","journal-title":"J Clin Invest"},{"key":"9049_CR19","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.3748\/wjg.v12.i31.5037","volume":"12","author":"G Theodoropoulos","year":"2006","unstructured":"Theodoropoulos G, Papaconstantinou I, Felekouras E, Nikiteas N, Karakitsos P, Panoussopoulos D, Lazaris A, Patsouris E, Bramis J, Gazouli M (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 12:5037\u20135043","journal-title":"World J Gastroenterol"},{"key":"9049_CR20","first-page":"3560","volume":"63","author":"S Landi","year":"2003","unstructured":"Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63:3560\u20133566","journal-title":"Cancer Res"},{"key":"9049_CR21","first-page":"277","volume":"49","author":"CE Hayes","year":"2003","unstructured":"Hayes CE, Nashold FE, Spach KM, Pedersen LB (2003) The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49:277\u2013300","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"9049_CR22","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","volume":"17","author":"M Froicu","year":"2003","unstructured":"Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17:2386\u20132392","journal-title":"Mol Endocrinol"},{"key":"9049_CR23","doi-asserted-by":"crossref","unstructured":"Park K, Woo M, Nam J, Kim JC. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Letters (in Press, corrected proof)","DOI":"10.1016\/j.canlet.2005.05.048"},{"key":"9049_CR24","first-page":"869","volume":"10","author":"HS Kim","year":"2001","unstructured":"Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD (2001) Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 10:869\u2013874","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1011292002475","volume":"12","author":"SA Ingles","year":"2001","unstructured":"Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW (2001) Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 12:607\u2013614","journal-title":"Cancer Causes Control"},{"key":"9049_CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1011280518278","volume":"12","author":"ML Slattery","year":"2001","unstructured":"Slattery ML, Yakumo K, Hoffman M, Neuhausen S (2001) Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 12:359\u2013364","journal-title":"Cancer Causes Control"},{"key":"9049_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/carcin\/bgg059","volume":"24","author":"HL Wong","year":"2003","unstructured":"Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA (2003) Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 24:1091\u20131095","journal-title":"Carcinogenesis"},{"key":"9049_CR28","first-page":"1267","volume":"10","author":"U Peters","year":"2001","unstructured":"Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10:1267\u20131274","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0303-7207(01)00406-3","volume":"177","author":"GK Whitfield","year":"2001","unstructured":"Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145\u2013159","journal-title":"Mol Cell Endocrinol"},{"key":"9049_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/mend.14.3.0435","volume":"14","author":"PW Jurutka","year":"2000","unstructured":"Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14:401\u2013420","journal-title":"Mol Endocrinol"},{"key":"9049_CR31","unstructured":"http:\/\/seer.cancer.gov\/publications\/ethnicity\/colorect.pdf"},{"key":"9049_CR32","first-page":"75","volume":"57","author":"ML Slattery","year":"1997","unstructured":"Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD (1997) Energy balance and colon cancer\u2013beyond physical activity. Cancer Res 57:75\u201380","journal-title":"Cancer Res"},{"key":"9049_CR33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/oxfordjournals.aje.a117192","volume":"140","author":"S Edwards","year":"1994","unstructured":"Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, Palmer P, Potter JD (1994) Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140:1020\u20131028","journal-title":"Am J Epidemiol"},{"key":"9049_CR34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0002-8223(94)91944-5","volume":"94","author":"ML Slattery","year":"1994","unstructured":"Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, Kerber R (1994) A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94:761\u2013766","journal-title":"J Am Diet Assoc"},{"key":"9049_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.CCM.0000150025.79100.7D","volume":"33","author":"E Watanabe","year":"2005","unstructured":"Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T (2005) Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 33:89\u201397; discussion 242\u2013243","journal-title":"Crit Care Med"},{"key":"9049_CR36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/1055-9965.EPI-05-0814","volume":"15","author":"C Sweeney","year":"2006","unstructured":"Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML (2006) Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 15:744\u2013749","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR37","unstructured":"Slattery ML KA, Levin TR (1993) Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Submitted, March 2003.Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer a review of the epidemiology. Epidemiol Rev 15:499\u2013545"},{"key":"9049_CR38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1023\/A:1020611416907","volume":"13","author":"NJ Camp","year":"2002","unstructured":"Camp NJ, Slattery ML (2002) Classification tree analysis: a statistical tool to investigate risk factor interactions with an example for colon cancer (United States). Cancer Causes Control 13:813\u2013823","journal-title":"Cancer Causes Control"},{"key":"9049_CR39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/1055-9965.538.13.4","volume":"13","author":"ML Slattery","year":"2004","unstructured":"Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, Neuhausen S (2004) Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 13:538\u2013545","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10552-005-0411-6","volume":"17","author":"ML Slattery","year":"2006","unstructured":"Slattery ML, Curtin K, Wolff R, Ma KN, Sweeney C, Murtaugh M, Potter JD, Levin TR, Samowitz W (2006) PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control 17:239\u2013249","journal-title":"Cancer Causes Control"},{"key":"9049_CR41","first-page":"1098","volume":"57","author":"J Ma","year":"1997","unstructured":"Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098\u20131102","journal-title":"Cancer Res"},{"key":"9049_CR42","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673\u20131677","journal-title":"Science"},{"key":"9049_CR43","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/jps.2600571218","volume":"57","author":"V Fang","year":"1968","unstructured":"Fang V, Foye WO, Robinson SM, Jenkins HJ (1968) Hypoglycemic activity and chemical structure of the salicylates. J Pharm Sci 57:2111\u20132116","journal-title":"J Pharm Sci"},{"key":"9049_CR44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/diab.9.5.416","volume":"9","author":"I Graef","year":"1960","unstructured":"Graef I, Gibbons DM (1960) Salicylates and carbohydrate metabolism. Diabetes 9:416\u2013418","journal-title":"Diabetes"},{"key":"9049_CR45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/diab.15.10.730","volume":"15","author":"ED Powell","year":"1966","unstructured":"Powell ED, Field RA (1966) Studies on salicylates and complement in diabetes. Diabetes 15:730\u2013733","journal-title":"Diabetes"},{"key":"9049_CR46","first-page":"1287","volume":"8","author":"JR McRae","year":"1980","unstructured":"McRae JR, Chen M, Robertson RP (1980) Improvement of defective insulin responses to glucose, arginine, and beta-adrenergic stimulation in diabetics by sodium salicylate. Adv Prostaglandin Thromboxane Res 8:1287\u20131289","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"9049_CR47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diacare.5.1.64","volume":"5","author":"SH Baron","year":"1982","unstructured":"Baron SH (1982) Salicylates as hypoglycemic agents. Diabetes Care 5:64\u201371","journal-title":"Diabetes Care"},{"key":"9049_CR48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","volume":"109","author":"RS Hundal","year":"2002","unstructured":"Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321\u20131326","journal-title":"J Clin Invest"},{"key":"9049_CR49","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1055-9965.EPI-06-0042","volume":"15","author":"MJ Gunter","year":"2006","unstructured":"Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15:1126\u20131131","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9049_CR50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1136\/gut.33.12.1660","volume":"33","author":"MG Thomas","year":"1992","unstructured":"Thomas MG, Tebbutt S, Williamson RC (1992) Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33:1660\u20131663","journal-title":"Gut"},{"key":"9049_CR51","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/diabetes.51.7.2294","volume":"51","author":"BW Ogunkolade","year":"2002","unstructured":"Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA (2002) Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51:2294\u20132300","journal-title":"Diabetes"},{"key":"9049_CR52","first-page":"589","volume":"15","author":"F Rozen","year":"1999","unstructured":"Rozen F, Pollak M (1999) Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins. Int J Oncol 15:589\u2013594","journal-title":"Int J Oncol"},{"key":"9049_CR53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","volume":"17","author":"U Zeitz","year":"2003","unstructured":"Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. Faseb J 17:509\u2013511","journal-title":"Faseb J"},{"key":"9049_CR54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.10580","volume":"89","author":"BD Mahon","year":"2003","unstructured":"Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922\u2013932","journal-title":"J Cell Biochem"},{"key":"9049_CR55","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","volume":"57","author":"AK Bhalla","year":"1983","unstructured":"Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308\u20131310","journal-title":"J Clin Endocrinol Metab"},{"key":"9049_CR56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0003-9861(02)00082-6","volume":"402","author":"CJ Bemiss","year":"2002","unstructured":"Bemiss CJ, Mahon BD, Henry A, Weaver V, Cantorna MT (2002) Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch Biochem Biophys 402:249\u2013254","journal-title":"Arch Biochem Biophys"},{"key":"9049_CR57","doi-asserted-by":"crossref","unstructured":"Yee YK, Chintalacharuvu SR, Lu J, Nagpal S Vitamin D receptor modulators for inflammation, cancer (2005) Mini Rev Med Chem 5:761\u2013778","DOI":"10.2174\/1389557054553785"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-007-9049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-007-9049-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-007-9049-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T19:28:24Z","timestamp":1684006104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-007-9049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,13]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,29]]}},"alternative-id":["9049"],"URL":"https:\/\/doi.org\/10.1007\/s10552-007-9049-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,13]]}}}